Second Roche Genome Sequencer FLX+ installed

June 22, 2012

Today we got a second Roche Genome Sequencer FLX+. The system is part of the in-kind contributions from Roche in the Oncotrack project (wwww.oncotrack.org). We will use this system especially for full length transcriptome analysis to detect new fusion genes and splice-sites in colon cancer samples.
The Sequencing Core Facility has now four Roche Systems running (2 GS FLX+, 1 FLX and 1 Gs Junior). The main advantage of the Roche/454 technology is the read length of up to 1000 bases with a typical modal read length on our site of around 800 bases. The 454 technology offers a great benefit especially for de novo genome sequencing, metagenome analysis, full length transcriptome analysis and amplicon sequencing.